Addressing Social Determinants of Health in Hidradenitis Suppurativa Care

Panelist discusses how social determinants of health create significant diagnostic barriers for hidradenitis suppurativa through systemic inequities, limited health care access, and provider knowledge gaps. Health systems can mitigate these challenges through targeted educational, technological, and culturally responsive interventions.

EP: 1.Bridging the Gap in Recognizing Early Symptoms of Hidradenitis Suppurativa

EP: 2.Improving HS Diagnosis and Care Through Better Alignment of Staging and Severity

Now Viewing

EP: 3.Addressing Social Determinants of Health in Hidradenitis Suppurativa Care

Video content above is prompted by the following:

• How do social determinants of health create barriers to timely and accurate diagnosis of HS?
• What strategies can health systems implement to mitigate these barriers?

Related Videos

Related Content

Advertisement

January 10th 2025

Researchers Identify Potential Novel Indicator of Dysphagia in MG

AJMC Contributor

Respiratory patterns and submental surface electromyography may be a reliable indicator of dysphagia among patients with myasthenia gravis.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

January 9th 2025

Subcutaneous Isatuximab Meets Primary End Points in Phase 3 Study for MM

Mary Caffrey

If the subcutaneous delivery method gains approval, an advantage daratumumab holds over isatuximab would be removed.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

January 9th 2025

New Research Links Gender, Racial Microaggressions to Higher Postpartum Blood Pressure

Giuliana Grossi

Acts of discrimination, including subtle microaggressions, during pregnancy and childbirth contribute to higher maternal mortality rates, especially among Black women, and are linked to increased postpartum blood pressure, highlighting the need for improved health care interventions and racial equity in maternity care.

January 8th 2025

Ruxolitinib Combinations in MPNs: Updates From ASH

Mary Caffrey

For several years, investigators have been studying combinations that include ruxolitinib, sold as Jakafi, to treat myeloproliferative neoplasms (MPNs).

Related Content

Advertisement

January 10th 2025

Researchers Identify Potential Novel Indicator of Dysphagia in MG

AJMC Contributor

Respiratory patterns and submental surface electromyography may be a reliable indicator of dysphagia among patients with myasthenia gravis.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

January 9th 2025

Subcutaneous Isatuximab Meets Primary End Points in Phase 3 Study for MM

Mary Caffrey

If the subcutaneous delivery method gains approval, an advantage daratumumab holds over isatuximab would be removed.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

January 9th 2025

New Research Links Gender, Racial Microaggressions to Higher Postpartum Blood Pressure

Giuliana Grossi

Acts of discrimination, including subtle microaggressions, during pregnancy and childbirth contribute to higher maternal mortality rates, especially among Black women, and are linked to increased postpartum blood pressure, highlighting the need for improved health care interventions and racial equity in maternity care.

January 8th 2025

Ruxolitinib Combinations in MPNs: Updates From ASH

Mary Caffrey

For several years, investigators have been studying combinations that include ruxolitinib, sold as Jakafi, to treat myeloproliferative neoplasms (MPNs).